Kimball P,Stravitz TDR . Antigens influence graft outcome and HCV recurrence after liver transplantation .Blockade of intragraft IL-2 receptor-alpha by basiliximab is insufficient to prevent activation of liver graft infiltrating cells .Liver recipients h ......